Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bellevue Life Sciences Acquisition Corp
Free Cash Flow
Bellevue Life Sciences Acquisition Corp
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
|
Free Cash Flow
-$818.8k
|
CAGR 3-Years
-245%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Free Cash Flow
-$566.2m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
-11%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Free Cash Flow
-$115.4m
|
CAGR 3-Years
-125%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Free Cash Flow
-$189.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Free Cash Flow
-$1.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Free Cash Flow
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bellevue Life Sciences Acquisition Corp
Glance View
Bellevue Life Sciences Acquisition Corp. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The firm has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business industry or sector. The firm intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The firm neither engaged in any operations nor generated any revenues.
See Also
What is Bellevue Life Sciences Acquisition Corp's Free Cash Flow?
Free Cash Flow
-818.8k
USD
Based on the financial report for Dec 31, 2023, Bellevue Life Sciences Acquisition Corp's Free Cash Flow amounts to -818.8k USD.
What is Bellevue Life Sciences Acquisition Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-245%
The average annual Free Cash Flow growth rates for Bellevue Life Sciences Acquisition Corp have been -245% over the past three years .
